成年息治疗患者的的药理学干预措施
Christopher Boehlke1, Lisa Joos2, Bettina Coune2
1Department of Palliative Care, University Hospital, Basel, Switzerland.
The Cochrane database of systematic reviews
|June 14, 2023
概括
本综述评估了在息护理患者中治疗的药理疗法. GABA-类别和卡帕-阿片类受体激活剂在尿素性方面表现出有效性,但证据质量不同.
科学领域:
- 药理学和息治疗
- 系统性审查和元分析
- 基于证据的医学基于证据的医学.
背景情况:
- 是息治疗中的一个沉重的症状,对患者的生活质量产生负面影响.
- 了解有效的药理疗法对于管理这种令人痛苦的症状至关重要.
研究的目的:
- 评估各种药理疗法的有效性,以预防或治疗成人息护理患者的.
- 将这些治疗与活性对照或安慰剂进行比较.
主要方法:
- 进行了随机对照试验 (RCT) 的系统审查和元分析.
- 搜索了多个数据库 (CENTRAL,MEDLINE,Embase) 到2022年7月.
- 包括91项研究,涉及4652名参与者,评估51种不同的治疗方法.
主要成果:
- 与GABA类似的药物显示,尿素性 (UP) 的大幅减少,证据的确定性中等.
- 卡帕-阿片类受体激动剂显示了UP的轻微减少,证据的确定性很高.
- 其他治疗方法的证据,如蒙特卢卡斯特,鱼油/欧米茄-3脂肪酸和局部素,确定性从低到非常低不等.
结论:
- GABA-模拟物和卡帕-阿片类受体激活剂对尿素性有效,GABA-模拟物显示出更大的效果.
- 里芬素,纳尔特雷克松和弗卢梅醇显示出胆固醇性的潜力,尽管证据非常不确定.
- 需要进一步的研究,特别是癌症患者的,由于研究的局限性,研究结果应谨慎解释.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
209
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
209
Drugs for Treatment of Diarrhea-Predominant IBS
219
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
219
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
356
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
356
Cholinergic Antagonists: Therapeutic Uses
784
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
784
Methods of reducing fever
707
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
707
Peripheral Artery Disease III: Interprofessional Care
13
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
13


